Table 4. Previous chemotherapy (paraprotein type and response to “DD Protocol”) of nine patients with stage II multiple myeloma.
Number of patients | Previous chemotherapy courses | Paraprotein type and response to DD protocol |
---|---|---|
1 | 26 MP + 17 VBMCP | IgG – PR |
1 | 10 VAD | IgG – CR |
1 | 6 VAD | λ urine – CR |
1 | 4 COMP + 1 VBMCP | κ – CR |
2 | 6 COMP + 5 MP | IgG – CR, PD |
3 | None | κ – CR, IgG – CR, IgA – PR |
M = melphalan, P = prednisone, V or O = vincristine, B = bleomycin, C = cyclophosphamide, A = adriamycin, D = dexamethasone, IgG = myeloma immunoglobulin G type, IgA = myeloma immunoglobulin A type, λ = myeloma lambda type, κ = myeloma kappa type, PR = partial response, CR = complete response, PD = progressive disease.